-
SLU-PP-332 is an investigational compound under study for its ability to reproduce some of the physiological effects typically associated with exercise. Its mechanism of action involves activation of estrogen-related receptors (ERRα, ERRβ, and ERRγ), which are central regulators of energy metabolism. Through this pathway, the compound has been shown to enhance mitochondrial efficiency, increase fatty acid oxidation, and elevate overall energy expenditure. In preclinical studies involving both diet-induced and genetically obese mice, administration of SLU-PP-332 produced significant metabolic improvements. Animals receiving the compound demonstrated reduced fat mass and greater rates of fatty acid utilization, while food intake and physical activity remained unchanged. These findings suggest that the compound alters systemic energy balance, creating a more favorable metabolic profile without requiring lifestyle modification. Additional investigations have highlighted the compound’s effects on skeletal muscle physiology. Treatment was associated with a higher proportion of oxidative muscle fibers, a shift that supports endurance capacity. Functional outcomes reflected this change, as mice receiving SLU-PP-332 exhibited prolonged exercise tolerance. Mechanistic studies attributed these effects to enhanced mitochondrial respiration and improved cellular bioenergetics within muscle tissue. -
KPV is a synthetic tripeptide (a short chain of three amino acids: lysine-proline-valine) that is derived from the larger hormone alpha-melanocyte stimulating hormone (α-MSH). It is a small peptide drug candidate with strong anti-inflammatory and protective properties, derived from the larger α-MSH hormone, and is being investigated as a targeted therapy for inflammatory disorders. -
CJC-1295 No DAC (Modified GRF) is a shortened peptide derivative of growth hormone–releasing hormone (GHRH). Originally developed in the 1980s, studies on modGRF suggest it may support muscle repair and development, speed up wound recovery, enhance bone strength, boost fat metabolism, and promote overall metabolic health. Research also indicates it could play a role in regulating blood sugar levels and supporting immune function. -
CJC-1295 DAC is a synthetic peptide designed as an analog of growth hormone–releasing hormone (GHRH). Its primary purpose is to stimulate the pituitary gland to release more growth hormone, which subsequently elevates levels of IGF-1 (insulin-like growth factor 1). What sets the DAC version apart from the non-DAC form is the addition of a “Drug Affinity Complex.” This chemical modification allows CJC-1295 DAC to bind to albumin in the bloodstream, extending its half-life from just minutes to several days. Because of this extended duration, a single administration can keep growth hormone levels elevated for nearly a week, making it significantly more efficient in terms of dosing frequency compared to its short-lived counterpart. In research contexts, CJC-1295 DAC has been studied for its potential to promote tissue repair, support lean muscle growth, improve fat metabolism, enhance sleep quality, and contribute to overall cellular rejuvenation. These effects are largely connected to the consistent elevation of growth hormone and IGF-1, which play central roles in recovery, metabolism, and anti-aging pathways. Despite these promising avenues, CJC-1295 DAC remains a research chemical rather than an approved therapeutic drug. Human studies are limited, and while side effects observed have included injection site reactions, water retention, flushing, and tingling, the long-term implications are not yet fully understood. Because of this, its use outside of supervised research carries risks, and it is not approved by regulatory authorities for medical treatment. -
Tesamorelin 5mg, Ipamorelin 5mg (10 mg total blend) -
Ipamorelin is a synthetic pentapeptide originally developed by Novo Nordisk as part of their exploration of selective growth hormone secretagogues. Structurally, it is a short chain of five amino acids, designed to act as an agonist at the ghrelin or growth hormone secretagogue receptor (GHS-R1a). By binding to this receptor in the hypothalamus and pituitary gland, ipamorelin mimics the activity of the natural “hunger hormone” ghrelin, stimulating the pituitary to release growth hormone (GH) in a pulsatile and physiologically natural rhythm. This mechanism contrasts with direct growth hormone injections, which deliver GH in a non-pulsatile, supra-physiological manner. -
BPC-157: A stable pentadecapeptide originally isolated from gastric juice, BPC-157 is recognized for its ability to stimulate new blood vessel formation, encourage fibroblast migration, and support epithelial repair. These effects are thought to involve modulation of VEGFR2 activity, FAK-paxillin signaling, and nitric oxide pathways. Preclinical studies suggest it promotes the healing of tendons, muscle tissue, and the gastrointestinal tract. TB-500 (Thymosin Beta-4 fragment): This 43-amino acid peptide regulates actin dynamics, facilitating cellular movement and tissue regeneration. It enhances repair processes by promoting angiogenesis (partly through VEGF upregulation), reducing inflammation, and mobilizing progenitor cells. Evidence indicates it may accelerate recovery in cardiac tissue, dermal layers, and connective structures. GHK-Cu: A naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) with broad regenerative activity. It has been shown to encourage wound repair, stimulate collagen and extracellular matrix production, and support hair growth. Mechanistically, it influences gene networks involved in tissue remodeling and exerts protective antioxidant and anti-inflammatory actions, partly through TGF-β signaling and regulation of metalloproteinases. -
CJC-1295 supports the body’s own production of growth hormone (GH) by activating the growth hormone–releasing hormone (GHRH) receptor. Ipamorelin is considered one of the most selective GH secretagogues and functions as a strong agonist of the ghrelin/GH secretagogue receptor. Research has investigated its potential in several areas, indicating benefits such as enhanced bone strength, accelerated muscle repair and growth, stimulation of pancreatic insulin release, and support for gastrointestinal activity and motility. When studied in combination, CJC-1295 and Ipamorelin have demonstrated complementary and synergistic effects on GH release. -
Sermorelin is a synthetic analogue of growth hormone–releasing hormone (GHRH) that is commonly used to evaluate and enhance endogenous growth hormone production. Research interest in sermorelin stems from its potential roles in promoting bone density, minimizing scar formation, mitigating cognitive decline associated with dementia, and reducing seizure occurrence. -
Oxytocin is a peptide hormone with key physiological roles in sexual reproduction, childbirth, maternal-infant bonding during lactation, and tissue repair. Beyond these established functions, emerging evidence indicates that oxytocin may enhance cognitive performance, reduce cardiovascular risk, and mitigate complications associated with diabetes. -
IGF-1 LR3 (Insulin-like Growth Factor-1 Long R3) is a synthetic, engineered variant of insulin-like growth factor-1 designed for enhanced stability and activity. Unlike native IGF-1, IGF-1 LR3 has a reduced affinity for IGF-binding proteins, allowing it to remain biologically active for up to 120 times longer. This extended half-life increases its physiological impact, promoting enhanced cell proliferation, fat metabolism, and muscle growth through the suppression of myostatin. Additionally, emerging studies indicate potential applications in supporting lactation in postpartum mothers. -
TB-500 (Thymosin Beta-4) is a synthetic peptide consisting of 43 amino acids. Preclinical studies in animal models indicate that Thymosin Beta-4 supports angiogenesis, modulates wound healing, reduces inflammation, and mitigates oxidative stress in both cardiac and neurological tissues. It plays a critical role in cytoprotection, tissue repair, regeneration, and structural remodeling following injury. Due to these properties, it has also attracted significant interest within the field of anti-aging research.
Need help? Call Or Text us, and a team member will be happy to assist you. +1 (570) 539-9711
Need help? Call Or Text us, and a team member will be happy to assist you.
+1 (570) 539-9711
We take pride in providing every client, whether large or small, with dedicated and respectful service.
We take pride in providing every client, whether large or small, with dedicated and respectful service.
© 2025
Licensedpeptides.com. All Rights Reserved.
LicensedPeptides is a licensed business entity supplying compounds for laboratory research purposes only. No products are approved for human use.
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind.
The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
Licensed peptides is a chemical supplier. Licensed peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Licensed peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.